| 13th May 2025 7:00 am |
RNS |
Director Shareholding - Share Purchase |
| 7th May 2025 7:00 am |
RNS |
Director Shareholding - Share Purchase |
| 2nd May 2025 11:14 am |
RNS |
Director/PDMR Shareholding |
| 28th Apr 2025 7:00 am |
RNS |
2024 Final Results |
| 23rd Apr 2025 7:00 am |
RNS-R |
Investor Presentation via Investor Meet Company |
| 22nd Apr 2025 7:00 am |
RNS |
TWO2® in NHS supply chain framework agreement |
| 9th Apr 2025 10:06 am |
RNS |
Notification of Major Holdings |
| 25th Mar 2025 5:59 pm |
RNS |
Director/PDMR Shareholding |
| 12th Feb 2025 7:00 am |
RNS |
Trading Update for the year ended 31 December 2024 |
| 24th Jan 2025 7:00 am |
RNS |
CORRECTION New Medicaid states, coverage expansion |
| 9th Jan 2025 7:00 am |
RNS |
New Medicaid states, payer coverage expansion |
| 17th Dec 2024 12:00 pm |
RNS |
Grant of performance share awards under LTIP |
| 16th Dec 2024 7:00 am |
RNS |
Enrolment Commences for VLU Clinical Trial |
| 12th Dec 2024 7:00 am |
RNS |
5 Year Veterans Administration Contract Extension |
| 20th Nov 2024 12:41 pm |
RNS |
Holding(s) in Company |
| 11th Nov 2024 7:00 am |
RNS |
CMS Topical Oxygen Therapy coverage review |
| 16th Sep 2024 7:00 am |
RNS |
2024 Interim Results |
| 15th Aug 2024 7:00 am |
RNS |
Pre-close Trading Update |
| 29th Jul 2024 7:00 am |
RNS |
US FDA 510(k) Clearance of NEXATM NPWT System |
| 21st Jun 2024 2:45 pm |
RNS |
Holding(s) in Company |
| 21st Jun 2024 1:41 pm |
RNS |
Holding(s) in Company |
| 18th Jun 2024 7:00 am |
RNS |
Admission to AIM and First Day of Dealings |
